MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 48 filers reported holding MERSANA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $119,267 | -6.1% | 16,704 | +0.2% | 0.00% | – |
Q3 2022 | $127,000 | +47.7% | 16,669 | -0.4% | 0.00% | – |
Q2 2022 | $86,000 | -98.2% | 16,737 | -98.6% | 0.00% | -100.0% |
Q1 2022 | $4,665,000 | +427.1% | 1,157,635 | +2004.4% | 0.00% | +100.0% |
Q1 2021 | $885,000 | +486.1% | 55,011 | +567.4% | 0.00% | – |
Q4 2020 | $151,000 | +228.3% | 8,243 | +233.6% | 0.00% | – |
Q3 2020 | $46,000 | -97.8% | 2,471 | -97.4% | 0.00% | -100.0% |
Q2 2020 | $2,116,000 | +8038.5% | 93,663 | +1953.6% | 0.00% | – |
Q4 2019 | $26,000 | +420.0% | 4,561 | +43.5% | 0.00% | – |
Q3 2019 | $5,000 | -58.3% | 3,179 | +5.3% | 0.00% | – |
Q2 2019 | $12,000 | +1100.0% | 3,019 | +1605.6% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 177 | +103.4% | 0.00% | – |
Q3 2018 | $1,000 | -80.0% | 87 | -69.3% | 0.00% | – |
Q2 2018 | $5,000 | +66.7% | 283 | +45.1% | 0.00% | – |
Q1 2018 | $3,000 | – | 195 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |